Movement disorders are associated with schizotypy in unaffected siblings of patients with non-affective psychosis

Psychological Medicine

Volumn 41, Issue 10, 2011, Pages 2141-2147

  Koning, J P ^a,b   Tenback, D E ^a,c   Kahn, R S ^b,c   Vollema, M G ^d   Cahn, W ^b,c   Van Harten, P N ^a,e  

^a Symfora Group Psychiatric Center   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Meerkanten GGZ Flevo Veluwe   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Movement disorders; psychosis risk; risk factors; schizophrenia; schizotypy; siblings

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; MOTOR DYSFUNCTION; NETHERLANDS; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOSIS; RISK FACTOR; SCHIZOTYPAL PERSONALITY DISORDER; SIBLING;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; NETHERLANDS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOTYPAL PERSONALITY DISORDER; SIBLINGS; YOUNG ADULT;

EID: 80054937942     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291711000389     Document Type: Article

References (43)

1. Abi-Dargham A, Kegeles LS, Zea-Ponce Y, Mawlawi O, Martinez D, Mitropoulou V, O'Flynn K, Koenigsberg HW, Van Heertum R, Cooper T, Laruelle M, Siever LJ (2004). Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biological Psychiatry 55, 1001-1006. (Pubitemid 38584612)
2. APA (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision. American Psychiatric Association: Washington, DC.
3. Appels MC, Sitskoorn MM, Vollema MG, Kahn RS (2004). Elevated levels of schizotypal features in parents of patients with a family history of schizophrenia spectrum disorders. Schizophrenia Bulletin 30, 781-790. (Pubitemid 40469515)
4. Barnes TR (1989). A rating scale for drug-induced akathisia. British Journal of Psychiatry 154, 672-676. (Pubitemid 19154942)
5. Calkins ME, Curtis CE, Grove WM, Iacono WG (2004). Multiple dimensions of schizotypy in first degree biological relatives of schizophrenia patients. Schizophrenia Bulletin 30, 317-325. (Pubitemid 38828538)
6. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R (2008). Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry 65, 28-37.
7. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC, Gottesman II, Farmer AE, McGuffin P, Reveley AM, Murray RM (1999). Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Archives of General Psychiatry 56, 162-168. (Pubitemid 29081391)
8. Carlsson A (1988). The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1, 179-186. (Pubitemid 19126130)
9. Casey DE (2004). Pathophysiology of antipsychotic drug-induced movement disorders. Journal of Clinical Psychiatry 65 (Suppl. 9), 25-28.
10. Dean CE, Russell JM, Kuskowski MA, Caligiuri MP, Nugent SM (2004). Clinical rating scales and instruments: how do they compare in assessing abnormal, involuntary movements? Journal of Clinical Psychopharmacology 24, 298-304. (Pubitemid 38658038)
11. Delawalla Z, Barch DM, Fisher Eastep JL, Thomason ES, Hanewinkel MJ, Thompson PA, Csernansky JG (2006). Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia. Schizophrenia Bulletin 32, 525-537. (Pubitemid 43992326)
12. Egan MF, Hyde TM, Bonomo JB, Mattay VS, Bigelow LB, Goldberg TE, Weinberger DR (2001). Relative risk of neurological signs in siblings of patients with schizophrenia. American Journal of Psychiatry 158, 1827-1834. (Pubitemid 33054775)
13. Glazer WM (2000). Review of incidence studies of tardive dyskinesia associated with typical antipsychotics. Journal of Clinical Psychiatry 61 (Suppl. 4), 15-20. (Pubitemid 30158598)
14. Grove WM, Lebow BS, Clementz BA, Cerri A, Medus C, Iacono WG (1991). Familial prevalence and coaggregation of schizotypy indicators: a multitrait family study. Journal of Abnormal Psychology 100, 115-121.
15. Guy W (1976). Abnormal Involuntary Movement Scale (AIMS). In ECDEU Assessment Manual for Psychopharmacology, pp. 534-537. National Institute of Mental Health, U.S. Department Health and Human Services: Rockville, MD.
16. Howes OD, Kapur S (2009). The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophrenia Bulletin 35, 549-562.
17. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM (2009). Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Archives of General Psychiatry 66, 13-20.
18. Huttunen J, Heinimaa M, Svirskis T, Nyman M, Kajander J, Forsback S, Solin O, Ilonen T, Korkeila J, Ristkari T, McGlashan T, Salokangas RK, Hietala J (2008). Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia. Biological Psychiatry 63, 114-117. (Pubitemid 350234886)
19. Ismail B, Cantor-Graae E, McNeil TF (1998). Neurological abnormalities in schizophrenic patients and their siblings. American Journal of Psychiatry 155, 84-89. (Pubitemid 28037553)
20. Kendler KS, Thacker L, Walsh D (1996). Self-report measures of schizotypy as indices of familial vulnerability to schizophrenia. Schizophrenia Bulletin 22, 511-520. (Pubitemid 26295353)
21. Koning JP, Kahn RS, Tenback DE, van Schelven LJ, van Harten PN (2011). Movement disorders in nonpsychotic siblings of patients with nonaffective psychosis. Psychiatry Research. Published online : 31 January 2011. doi:10.1016/j.psychres.2011.01.005.
22. Koning JP, Tenback DE, van Os J, Aleman A, Kahn RS, van Harten PN (2010). Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophrenia Bulletin 36, 723-731.
23. Laurent A, Biloa-Tang M, Bougerol T, Duly D, Anchisi AM, Bosson JL, Pellat J, d'Amato T, Dalery J (2000). Executive/attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives. Schizophrenia Research 46, 269-283.
24. Lenzenweger MF (1993). Explorations in schizotypy and the psychometric high-risk paradigm. In Progress in Experimental Personality and Psychopathology Research (ed. L. J. Chapman, J. P. Chapman and D. Fowles), pp. 66-116. Springer: New York.
25. Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F (1994). Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Movement Disorders 9, 76-83. (Pubitemid 24022618)
26. Mechri A, Gassab L, Slama H, Gaha L, Saoud M, Krebs MO (2010). Neurological soft signs and schizotypal dimensions in unaffected siblings of patients with schizophrenia. Psychiatry Research 175, 22-26.
27. Mittal VA, Neumann C, Saczawa M, Walker EF (2008). Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia. Archives of General Psychiatry 65, 165-171. (Pubitemid 351214315)
28. Mittal VA, Walker EF (2007). Movement abnormalities predict conversion to Axis I psychosis among prodromal adolescents. Journal of Abnormal Psychology 116, 796-803.
29. Pappa S, Dazzan P (2009). Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review. Psychological Medicine 39, 1065-1076.
30. Peralta V, de Jalon EG, Campos MS, Basterra V, Sanchez-Torres A, Cuesta MJ (2010). Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders. Psychological Medicine. Published online: 22 September 2010. doi:10.1017/S0033291710001856.
31. Schiffman J, Walker E, Ekstrom M, Schulsinger F, Sorensen H, Mednick S (2004). Childhood videotaped social and neuromotor precursors of schizophrenia: a prospective investigation. American Journal of Psychiatry 161, 2021-2027. (Pubitemid 39441402)
32. Smith Y, Bevan MD, Shink E, Bolam JP (1998). Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86, 353-387. (Pubitemid 28293917)
33. Soliman A, O'Driscoll GA, Pruessner J, Holahan AL, Boileau I, Gagnon D, Dagher A (2008). Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study. Neuropsychopharmacology 33, 2033-2041. (Pubitemid 351832609)
34. Tenback DE, van Harten PN, Slooff CJ, van Os J (2010). Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia. Journal of Psychopharmacology 24, 1031-1035.
35. van Harten PN, Matroos GE, Hoek HW, Kahn RS (1996). The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia. The Curacao Extrapyramidal Syndromes Study: I. Schizophrenia Research 19, 195-203.
36. van Harten PN, Tenback DE (2009). Movement disorders should be a criterion for schizophrenia in DSM-V [Letter]. Psychological Medicine 39, 1754-1756.
37. van Os J, Kapur S (2009). Schizophrenia. Lancet 374, 635-645.
38. Vollema MG, Ormel J (2000). The reliability of the Structured Interview for Schizotypy-Revised. Schizophrenia Bulletin 26, 619-629.
39. Vollema MG, Sitskoorn MM, Appels MC, Kahn RS (2002). Does the Schizotypal Personality Questionnaire reflect the biological-genetic vulnerability to schizophrenia? Schizophrenia Research 54, 39-45. (Pubitemid 34164517)
40. Walker EF (1994). Developmentally moderated expressions of the neuropathology underlying schizophrenia. Schizophrenia Bulletin 20, 453-480. (Pubitemid 24251257)
41. Whitty PF, Owoeye O, Waddington JL (2009). Neurological signs and involuntary movements in schizophrenia : intrinsic to and informative on systems pathobiology. Schizophrenia Bulletin 35, 415-424.
42. Wolff AL, O'Driscoll GA (1999). Motor deficits and schizophrenia: the evidence from neuroleptic-naive patients and populations at risk. Journal of Psychiatry and Neuroscience 24, 304-314.
43. Yazici AH, Demir B, Yazici KM, Gogus A (2002). Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophrenia Research 58, 241-246. (Pubitemid 35284515)